Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Additional filings and positive clinical results for Zadaxin

Dec. 23, 1996

Takeda claims new treatments for pancreatitis

Dec. 23, 1996

Novel 5-HT4 receptor agonist claimed by Pharmacia & Upjohn

Dec. 13, 1996

Roberts in-licenses another GI drug from Lilly

Dec. 10, 1996

Successful phase III results reported for British Biotech PAF antagonist

Dec. 9, 1996

Cytel to implement new development strategy for HBV vaccine

Dec. 6, 1996

Phase IIa trial on Isis antiinflammatory antisense compound completed

Dec. 5, 1996

Axcan-Schwarz joint venture to market URSO

Dec. 2, 1996

Chugai discloses erythromycins for gastrointestinal disorders

Nov. 27, 1996

OraVax and Pasteur-Merieux Connaught license H. pylori genome sequence

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...